| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |